Thread

1. AbstractH24 · 1790194039 · focus · HN ↗

   I recently heard Anthropic quietly setup its own bio lab.

   That it’s plausible that they’ll move from selling tokens as their primary source of revenue to building frontier models to do cutting edge research, and using the research as their primary source of revenue rather than release the models. Because it’ll be far less of a race to the bottom than commodified tokens used by the general public.

   Will be interesting to see how this all unfolds. (No pun intended, but there is a funny one there…)

   1. spwa4 · 1790194331 · focus · HN ↗

      So they're already threatening their customers Amazon-style?

      Excellent. Now every pharma company, plus any kind of company that wants to own a market through innovation, will need a "world-class" AI research team that actually has spectacular AI budgets.

      1. AbstractH24 · 1790203619 · focus · HN ↗

         Pretty much

         The analogy to Amazon works on all sorts of levels. From Amazon.com vs AWS to Amazon.com vs sellers

Unofficial Hacker News client; not affiliated with Y Combinator.